- Shire's New Rare Disease Deal: Interesting Science Meets Unique Financing
- Biogen Idec Retools After ALS Drug Trial Failure
- GlaxoSmithKline Positioning For Clinical Trial Data Advantage
- Monsanto, Alnylam To Apply Genomics To Agricultural Pests
- Drug Companies Join NIH To Repurpose Current Drugs Into New Therapies
Alan Kotok
ABOUT
Alan Kotok is a Washington, DC-based reporter and writer on science, technology, business, and public policy, and editor and publisher of Science Business, an online news service on the value chain connecting scientific discovery with the marketplace. Kotok previously was managing editor of Science Careers, the online employment, career development, and funding portal of Science Magazine.
SNAPSHOT
- Description: Professional Blogger. Trading frequency: Infrequent
- Interests: Bonds, Dividend stock ideas & income, ETFs, Mutual funds, Retirement savings
COMPANY
Technology News & Literature Technology News & Literature can write, edit, produce, and distribute your electronic documentation for mobile apps and blog plug-ins.
BLOG
Science Business
Science Business is an online news service created for researchers, administrators, business people, government officials, and observers interested in what it takes to convert scientific knowledge into marketable products and services. On the site’s posts and pages, you can find news about new discoveries by ...More
Book
Cienfuegos Rainbow: Observations of a 21st Century Cuba An eight-day study tour of Cuba became an eye-opening experience that highlighted a country struggling to feed and house its population in the 21st century, while stuck in a confrontational cold war past. Alan and Sharon Kotok describe their experiences as part of a group of University of Iowa alumni who ...More
Latest Comments
more »
Latest comments on Alan Kotok's Articles
LATEST ARTICLES & INSTAPOSTS
more »